Skip to main content

Want a detailed portfolio tracker?

Fortress Biotech (FBIO) P/E (2011 - 2026)

Fortress Biotech (FBIO) P/E from Nov 17, 2011 to Jul 21, 2026. The TTM Fortress Biotech (FBIO) P/E is 0.90. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Fortress Biotech (FBIO)

YearP/EChange
20260.90-94.43%
202516.22-1693.11%
2024-1.02+221.89%
2023-0.32-58.23%
2022-0.76-80.37%
2021-3.86-35.11%
2020-5.94+37.56%
2019-4.32+666.05%
2018-0.56-79.17%
2017-2.71+3.12%
2016-2.63-3.12%
2015-2.71-49.35%
2014-5.35+137.57%
2013-2.25-33.44%
2012-3.38+210.21%
2011-1.09N/A

Comparison Fortress Biotech (FBIO) P/E with competitors

Fortress Biotech (FBIO) P/E is 0.90.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.81%
NBYStablecoin Development Corp0.00-99.52%
ENLVEnlivex Ltd0.07-91.72%
FGENFibroGen Inc0.24-73.42%
CHRSCoherus Biosciences Inc0.85-6.03%
ORMPOramed Pharmaceuticals Inc1.50+66.45%
AGENAgenus Inc3.01+233.30%
INVAInnoviva Inc3.15+249.29%
VXRTVaxart Inc3.55+293.11%
CRMDCorMedix Inc3.63+301.83%
CVACCureVac N.V.4.45+392.33%
GLPGGalapagos NV4.86+438.09%
SRPTSarepta Therapeutics Inc4.88+440.66%
ABEOAbeona Therapeutics Inc5.39+496.63%
ABUSArbutus Biopharma Corp5.60+519.68%
ZVRAZevra Therapeutics Inc5.89+551.97%
SPROSpero Therapeutics Inc6.23+589.76%
CGENCompugen Ltd6.31+599.23%
RIGLRigel Pharmaceuticals6.87+661.04%
SLXNSilexion Therapeutics Corp7.30+708.00%
OMEROmeros Corporation9.26+925.35%
AUPHAurinia Pharmaceuticals Inc9.58+961.48%
PLXProtalix BioTherapeutics Inc10.89+1106.11%
ACADAcadia Pharmaceuticals Inc11.73+1198.87%
TBPHTheravance Biopharma Inc12.26+1257.96%
ADMAAdma Biologics Inc12.42+1275.24%
HRMYHarmony Biosciences Holdings Inc13.82+1430.51%
SABSSAB Biotherapeutics Inc14.14+1465.50%
NAGENiagen Bioscience Inc14.82+1541.02%
INCYIncyte Corp15.82+1652.26%
REGNRegeneron Pharmaceuticals Inc15.86+1656.04%
PBYIPuma Biotechnology Inc17.32+1817.62%
CPRXCatalyst Pharmaceuticals Inc17.44+1831.31%
EXELExelixis Inc17.54+1842.24%
TGTXTG Therapeutics Inc18.97+2000.38%
MDXGMimedx Group Inc20.55+2176.08%
XOMAXOMA Royalty Corp22.87+2433.31%
ARGXArgen X SE24.30+2590.94%
CTMXCytomX Therapeutics Inc24.82+2648.87%
XOMAOXOMA Royalty Corp25.34+2706.87%
HALOHalozyme Therapeutics Inc25.62+2737.76%
XOMAPXOMA Royalty Corp25.67+2742.90%
VRTXVertex Pharmaceuticals Inc27.99+3000.34%
RPRXRoyalty Pharma plc - Class A28.69+3077.07%
SLNOSoleno Therapeutics Inc29.02+3113.37%
ASNDAscendis Pharma A/S30.09+3231.89%
LGNDLigand Pharmaceuticals Inc - Class B37.91+4098.65%
APLSApellis Pharmaceuticals Inc39.02+4221.50%
BMRNBiomarin Pharmaceutical Inc42.21+4574.85%
KRYSKrystal Biotech Inc45.34+4921.67%
ONCBeiGene Ltd69.54+7601.42%
PHARPharming Group N.V.75.03+8208.89%
TECHBio-Techne Corp101.96+11191.63%
VCELVericel Corp109.92+12073.50%
ALNYAlnylam Pharmaceuticals Inc117.96+12964.33%
GMABGenmab140.29+15436.84%
TLXTelix Pharmaceuticals Ltd162.15+17858.00%
CORTCorcept Therapeutics Inc212.86+23473.42%